![]() |
![]() |
(2R)-2-acetylamino-2-carboxyethanethiol (R)-2-Acetamido-3-mercaptopropanoic acid (S)-ALPHA-AMINO-2-NAPHTHALENEPROPIONIC ACID 2-(acetylamino)-3-sulfanylpropanoic acid AC-ASP-GLU AC-ASP-GLU H2O AC-ASP-GLU-OH Acetylcysteine ACETYL-D-E AC-L-CYS-OH Cysteine, N-acetyl- EINECS 210-498-3 Isospaglumic acid L-N-acetyl-cysteine MFCD00004880 NAAG NAAGA Naaxia N-ACETYL CYSTEINE N-acetyl-(R)-cysteine N-ACETYL-3-MERCAPTOALANINE N-acetyl-aspartatylglutamate N-acetylcycteine N-Acetylcysteine N-Acetyl-cysteine N-ACETYL-L-(+)-CYSTEINE N-acetyl-L-aspartyl-L-glutamate N-acetyl-L-aspartyl-L-glutamic acid N-ALPHA-ACETYL-L-CYSTEINE RARECHEM BK PT 0097 SPAGLUMIC ACID
Reported in EPA TSCA Inventory.
Poison by intraperitoneal route. Moderately toxic by other routes. Mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and SOx.
Risk Statements: 36/37/38
36/37/38: Irritating to eyes, respiratory system and skin?
Safety Statements: 22-24/25
22: Do not breathe dust
24/25: Avoid contact with skin and eyes
F?10-23: Keep under argon. Sensitive to air
WGK Germany: 3
? N-Acetyl-cysteine , with CAS number of 616-91-1, can be called (2R)-2-(acetylamino)-3-sulfanylpropanoic acid ; (2R)-2-Acetamido-3-sulfanylpropanoic acid ; 2-Acetylamino-3-mercapto-propionate ; Acetylcysteinum ; Acetilcisteina . It is a?white crystalline powder. N-Acetyl-cysteine (CAS NO.616-91-1) is a pharmaceutical drug used mainly as a mucolytic agent and in the management of paracetamol (acetaminophen) overdose. It is also used post-operatively, as a diagnostic aid, and in tracheotomy care. Oral N-Acetyl-cysteine is used for the prevention of radiocontrast-induced nephropathy. Besides can be used in Petroff's method i.e. liquefaction and decontamination of sputum, in preparation for diagnosis of tuberculosis.
1. | ??? |
mma-sat 8?μg/plate |
??? | CRNGDP ?? Carcinogenesis. 7 (1986),431. |
2. | ??? |
orl-rat LD50:5050?mg/kg |
??? | TXAPA9 ?? Toxicology and Applied Pharmacology. 18 (1971),185. |
3. | ??? |
ivn-rat LD50:1140?mg/kg |
??? | EJRDD2 ?? European Journal of Respiratory Diseases. 61 (Suppl 111),(1980),45. |
4. | ??? |
orl-mus LD50:7888?mg/kg |
??? | THEWA6 ?? Therapiewoche. 30 (1980),1926. |
5. | ??? |
ipr-mus LD50:400?mg/kg |
??? | NTIS** ?? National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) AD691-490 . |
6. | ??? |
ivn-mus LD50:3800?mg/kg |
??? | JMCMAR ?? Journal of Medicinal Chemistry. 10 (1967),1172. |
Not classified.
Pictogram(s) | No symbol. |
---|---|
Signal word | No signal word. |
Hazard statement(s) | none |
Precautionary statement(s) | |
Prevention | none |
Response | none |
Storage | none |
Disposal | none |
none
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Literatures:
Biochemical Journal, , vol. 25, p. 619 Biochemical Journal, , vol. 27, p. 1716 ![]() Yield: null |